非那雄胺与男性乳腺癌：药品和健康产品管理局的报告显示存在关联吗？
Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?
作者信息
Shenoy Niraj K, Prabhakar Sangolli M
机构信息
#301-B, Ranka Colony, Bilekahalli, Bannerghatta Road, Bangalore - 560 076, India.
出版信息
J Cutan Aesthet Surg. 2010 May;3(2):102-5. doi: 10.4103/0974-2077.69022.
Abstract
Finasteride is an important drug for the management of androgenetic alopecia. However, there are concerns about the possible side effects of the drug such as impotence. Recently stray reports have appeared about the occurrence of male breast carcinoma in patients who received the drug. These have been looked in to by Medicines and Health care products Regulatory Agency (MHRA). This article summarizes the MHRA report.
摘要
非那雄胺是治疗雄激素性脱发的一种重要药物。然而，人们担心该药物可能存在副作用，如阳痿。最近，有关于接受该药物治疗的患者发生男性乳腺癌的零星报道。药品和保健品管理局（MHRA）已对此进行了调查。本文总结了MHRA的报告。
相似文献
1
Finasteride and Male Breast Cancer: Does the MHRA Report Show a Link?非那雄胺与男性乳腺癌：药品和健康产品管理局的报告显示存在关联吗？
J Cutan Aesthet Surg. 2010 May;3(2):102-5. doi: 10.4103/0974-2077.69022.
2
Guidelines on the use of finasteride in androgenetic alopecia.非那雄胺治疗雄激素性脱发的指南。
Indian J Dermatol Venereol Leprol. 2016 Mar-Apr;82(2):128-34. doi: 10.4103/0378-6323.177432.
3
Dutasteride in Androgenetic Alopecia: An Update.度他雄胺治疗雄激素性脱发：最新进展
Curr Clin Pharmacol. 2017;12(1):31-35. doi: 10.2174/1574884712666170310111125.
4
Post-finasteride syndrome: An emerging clinical problem.非那雄胺后综合征：一个新出现的临床问题。
Neurobiol Stress. 2019 Dec 26;12:100209. doi: 10.1016/j.ynstr.2019.100209. eCollection 2020 May.
5
A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.一项多中心、随机、阳性药物对照、双盲临床试验，旨在评估不同剂量度他雄胺治疗男性雄激素性脱发的有效性和安全性。
J Am Acad Dermatol. 2014 Mar;70(3):489-498.e3. doi: 10.1016/j.jaad.2013.10.049. Epub 2014 Jan 9.
6
[Finasteride: a new drug for the treatment of male hirsutism and androgenetic alopecia?].非那雄胺：一种治疗男性多毛症和雄激素性脱发的新药？
Clin Ter. 1996 Jun;147(6):305-15.
7
Transdermal finasteride delivery via powder-carrying microneedles with a diffusion enhancer to treat androgenetic alopecia.经皮递送携粉微针联合扩散增强剂治疗雄激素性脱发。
J Control Release. 2019 Dec 28;316:1-11. doi: 10.1016/j.jconrel.2019.11.002. Epub 2019 Nov 2.
8
A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia.一项关于0.25%非那雄胺与3%米诺地尔混合外用溶液对比3%米诺地尔溶液治疗男性雄激素性脱发疗效和安全性的随机双盲对照研究。
J Eur Acad Dermatol Venereol. 2018 Dec;32(12):2257-2263. doi: 10.1111/jdv.15171. Epub 2018 Jul 20.
9
Controversies in the treatment of androgenetic alopecia: The history of finasteride.雄激素性脱发治疗的争议：非那雄胺的历史。
Dermatol Ther. 2019 Mar;32(2):e12647. doi: 10.1111/dth.12647. Epub 2018 Sep 25.
10
Superiority of dutasteride over finasteride in hair regrowth and reversal of miniaturization in men with androgenetic alopecia: A randomized controlled open-label, evaluator-blinded study.度他雄胺在男性雄激素性秃发患者毛发再生及毛囊小型化逆转方面优于非那雄胺：一项随机对照开放标签、评估者盲法研究。
Indian J Dermatol Venereol Leprol. 2017 Jan-Feb;83(1):47-54. doi: 10.4103/0378-6323.188652.
引用本文的文献
1
Vesical Endometriosis in a male patient on treatment for papillary urothelial carcinoma.一名正在接受乳头状尿路上皮癌治疗的男性患者出现膀胱子宫内膜异位症。
J West Afr Coll Surg. 2024 Jul-Sep;14(3):345-347. doi: 10.4103/jwas.jwas_130_23. Epub 2024 May 24.
2
Safety of Antiandrogens for the Treatment of Female Androgenetic Alopecia with Respect to Gynecologic Malignancies.抗雄激素药物治疗女性雄激素性脱发在妇科恶性肿瘤方面的安全性
J Clin Med. 2024 May 23;13(11):3052. doi: 10.3390/jcm13113052.
3
Pharmacological and interventional treatment of benign prostatic obstruction: An evidence-based comparative review.良性前列腺梗阻的药物及介入治疗：一项基于证据的比较性综述
BJUI Compass. 2021 Feb 3;2(4):238-259. doi: 10.1002/bco2.74. eCollection 2021 Jul.
4
The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs).接受5α还原酶抑制剂（5ARIs）治疗的良性前列腺增生男性发生静脉血栓栓塞（VTE）的风险
Clin Epidemiol. 2021 Aug 3;13:661-673. doi: 10.2147/CLEP.S317019. eCollection 2021.
5
Platelet Rich Plasma Hybridized Adipose Transplant (PHAT) for the Treatment of Hair Loss: A Case Series.富血小板血浆复合脂肪移植（PHAT）治疗脱发：病例系列。
Aesthetic Plast Surg. 2021 Dec;45(6):2760-2767. doi: 10.1007/s00266-021-02406-0. Epub 2021 Jul 8.
6
Finasteride and Its Potential for the Treatment of Female Pattern Hair Loss: Evidence to Date.非那雄胺及其治疗女性型脱发的潜力：现有证据。
Drug Des Devel Ther. 2020 Mar 2;14:951-959. doi: 10.2147/DDDT.S240615. eCollection 2020.
7
Finasteride treatment and male breast cancer: a register-based cohort study in four Nordic countries.非那雄胺治疗与男性乳腺癌：四个北欧国家基于注册的队列研究。
Cancer Med. 2018 Jan;7(1):254-260. doi: 10.1002/cam4.1273. Epub 2017 Dec 13.
8
Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review.5α-还原酶抑制剂与男性乳腺癌风险：一项系统评价
Ann Dermatol. 2017 Aug;29(4):525-528. doi: 10.5021/ad.2017.29.4.525. Epub 2017 Jun 21.
9
Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome.5α-还原酶抑制剂综合征合理性的调查。
Skin Appendage Disord. 2017 Jan;2(3-4):120-129. doi: 10.1159/000450617. Epub 2016 Sep 23.
10
[Drug treatment of alopecia].[脱发的药物治疗]
Internist (Berl). 2015 Oct;56(10):1196-208. doi: 10.1007/s00108-015-3763-3.
本文引用的文献
1
Intratumoral estrogen production in breast carcinoma: significance of aromatase.乳腺癌瘤内雌激素的产生：芳香化酶的意义。
Breast Cancer. 2008;15(4):270-7. doi: 10.1007/s12282-008-0062-z. Epub 2008 Jul 12.
2
Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum testosterone.单独使用外源性睾酮或与非那雄胺联合使用，对于血清睾酮水平较低的健康老年男性，并不会改善其认知测量结果。
J Androl. 2007 Nov-Dec;28(6):875-82. doi: 10.2164/jandrol.107.002931. Epub 2007 Jul 3.
3
Invasive lobular carcinoma of the male breast.男性乳腺浸润性小叶癌。
Can J Surg. 2006 Oct;49(5):365-6.
4
Survival of male breast cancer patients: a population-based study in Osaka, Japan.男性乳腺癌患者的生存情况：一项基于日本大阪人群的研究。
Jpn J Clin Oncol. 2006 Nov;36(11):699-703. doi: 10.1093/jjco/hyl095. Epub 2006 Sep 29.
5
Male breast cancer.男性乳腺癌
Lancet. 2006 Feb 18;367(9510):595-604. doi: 10.1016/S0140-6736(06)68226-3.
6
Estrogen carcinogenesis in breast cancer.雌激素与乳腺癌致癌作用
N Engl J Med. 2006 Jan 19;354(3):270-82. doi: 10.1056/NEJMra050776.
7
Epidemiology of male breast cancer.男性乳腺癌的流行病学
Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):20-6.
8
Finasteride in benign prostatic hyperplasia.
N Engl J Med. 2004 Mar 25;350(13):1359-61; author reply 1359-61. doi: 10.1056/NEJMc045013.
9
Is male breast cancer similar or different than female breast cancer?男性乳腺癌与女性乳腺癌相似还是不同？
Breast Cancer Res Treat. 2004 Jan;83(1):77-86. doi: 10.1023/B:BREA.0000010701.08825.2d.
10
Male breast cancer during finasteride therapy.非那雄胺治疗期间发生的男性乳腺癌。
J Natl Cancer Inst. 2004 Feb 18;96(4):338-9. doi: 10.1093/jnci/djh062.
Zotero 插件